NeoGenomics, Inc.
NEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$78,726 | -$87,968 | -$144,250 | -$8,347 |
| Dep. & Amort. | $72,547 | $72,583 | $69,430 | $53,352 |
| Deferred Tax | $0 | $0 | -$16,098 | $0 |
| Stock-Based Comp. | $33,413 | $24,633 | $24,672 | $22,458 |
| Change in WC | -$32,630 | -$25,493 | -$31,701 | -$4,600 |
| Other Non-Cash | $12,419 | $14,292 | $31,954 | -$89,586 |
| Operating Cash Flow | $7,023 | -$1,953 | -$65,993 | -$26,723 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$41,061 | -$28,752 | -$30,891 | -$64,142 |
| Net Acquisitions | $0 | $0 | $0 | -$419,404 |
| Inv. Purchases | $0 | -$6,756 | -$97,605 | -$196,791 |
| Inv. Sales/Matur. | $53,916 | $112,215 | $116,915 | $62,970 |
| Other Inv. Act. | $0 | $0 | $12,098 | -$15,000 |
| Investing Cash Flow | $12,855 | $76,707 | $517 | -$632,367 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$70 | -$758 | $334,410 |
| Stock Issued | $4,646 | $4,624 | $12,587 | $423,213 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$32,338 |
| Financing Cash Flow | $4,646 | $4,554 | $11,829 | $725,285 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $24,524 | $79,308 | -$53,647 | $66,195 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $342,488 | $263,180 | $316,827 | $250,632 |
| End Cash | $367,012 | $342,488 | $263,180 | $316,827 |
| Free Cash Flow | -$34,038 | -$30,705 | -$96,884 | -$90,865 |